You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 10, October 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acetazolamide for Treatment of Chronic Macular Edema in Retinitis Pigmentosa

Gerald A. Fishman, MD; Leonardo D. Gilbert, COT; Richard G. Fiscella, RPh, MPH; Alan E. Kimura, MD; Lee M. Jampol, MD

Arch Ophthalmol. 1989;107(10):1445-1452.


Abstract

• Twelve patients with retinitis pigmentosa and chronic macular edema were prospectively treated for 2-week periods with acetazolamide or a placebo in a masked, crossover study. Ten of the 12 patients had both subjective and objective improvement in visual acuity when treated with acetazolamide. Improvement was seen even in patients with an acuity as good as 20/25 at baseline as well as in patients with macular edema present for more than a decade. A dosage of 500 mg/d was found to be more effective than 250 mg/d. Six patients (50%) showed lessening of their macular edema on fluorescein angiography. This angiographically demonstrated improvement was predominantly due to less detectable leakage from retinal capillaries rather than from choroidal capillaries through the retinal pigment epithelium. Improvement in visual acuity was seen in some patients without a detectable change in the amount of angiographic fluorescein leakage.



Author Affiliations

From the Departments of Ophthalmology, University of Illinois at Chicago (Dr Fishman and Messrs Gilbert and Fiscella), University of Iowa, Iowa City (Dr Kimura), and Northwestern University, Chicago (Dr Jampol).


Footnotes

Accepted for publication June 29, 1989.

Reprint requests to University of Illinois at Chicago, 1855 W Taylor St, Chicago, IL 60612 (Dr Fishman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unilateral macular oedema in Zermatt and Stargardt macular dystrophies
Abouzeid et al.
Br J Ophthalmol 2009;93:1376-1377.
FULL TEXT  

CO2-induced ion and fluid transport in human retinal pigment epithelium
Adijanto et al.
JGP 2009;133:603-622.
ABSTRACT | FULL TEXT  

Management of Autoimmune Retinopathies With Immunosuppression
Ferreyra et al.
Arch Ophthalmol 2009;127:390-397.
ABSTRACT | FULL TEXT  

The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography
Hajali et al.
Br J Ophthalmol 2008;92:1065-1068.
ABSTRACT | FULL TEXT  

Treatment of Cystoid Macular Edema in Retinitis Pigmentosa With Intravitreal Triamcinolone
Scorolli et al.
Arch Ophthalmol 2007;125:759-764.
ABSTRACT | FULL TEXT  

Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa
Fishman and Apushkin
Br J Ophthalmol 2007;91:743-745.
ABSTRACT | FULL TEXT  

The Retinal Pigment Epithelium in Visual Function
Strauss
Physiol. Rev. 2005;85:845-881.
ABSTRACT | FULL TEXT  

Disease Expression in Usher Syndrome Caused by VLGR1 Gene Mutation (USH2C) and Comparison with USH2A Phenotype
Schwartz et al.
IOVS 2005;46:734-743.
ABSTRACT | FULL TEXT  

Outcome of cataract surgery in patients with retinitis pigmentosa
Jackson et al.
Br J Ophthalmol 2001;85:936-938.
ABSTRACT | FULL TEXT  

Effects of Acetazolamide on Passive and Active Transport of Fluorescein across the Normal BRB
Moldow et al.
IOVS 1999;40:1770-1775.
ABSTRACT | FULL TEXT  

Electrophysiological evaluation of visual loss in Muller cell sheen dystrophy
Kellner et al.
Br J Ophthalmol 1998;82:650-654.
ABSTRACT | FULL TEXT  

Prevalence of Foveal Lesions in Type 1 and Type 2 Usher's Syndrome
Fishman et al.
Arch Ophthalmol 1995;113:770-773.
ABSTRACT  

Hyperbaric Oxygen and Acetazolamide Improve Visual Acuity in Patients With Cystoid Macular Edema by Different Mechanisms
Miyake et al.
Arch Ophthalmol 1993;111:1605-1606.
ABSTRACT  

Rebound of Macular Edema With Continued Use of Methazolamide in Patients With Retinitis Pigmentosa
Fishman et al.
Arch Ophthalmol 1993;111:1640-1646.
ABSTRACT  

Hypothesis Concerning Carbonic Anhydrase Treatment of Cystoid Macular Edema: Example With Epiretinal Membrane
Marmor
Arch Ophthalmol 1990;108:1524-1525.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.